Sharp offers numerous heart-related clinical trials. These trials are vital to finding and advancing heart treatment options and play a key role in saving the lives of more heart patients.

Research improves lives.

We are currently involved in studies covering the following:

• Coronary artery blockage angioplasty and stenting treatment
• Cardiac medications, such as blood thinners or anticoagulants and their reversal agents
• Use of technology for early detection of subclinical atrial fibrillation/atrial tachyarrhythmia and device malfunction on patients with cardiac implantable electronic devices
• Medication alternatives for the prevention of atrial fibrillation-related strokes
• Nonsurgical treatment options for aortic stenosis

Enroll in an active clinical trial.

If you are interested in participating in a clinical trial, please consult with your physician or contact the Sharp Center for Research at 858-939-7198 or send us an email.

• NCT02389946 - coronary artery disease, atherosclerosis, coronary myocardial ischemia, ischemic heart disease, acute coronary syndrome, angina pectoris; sponsored by Biotronik, Inc., study for Orsiro Sirolimus Eluting Coronary Stent System
• NCT02290028 - heart failure, sponsored by Biotronik, Inc., study drugs Sentus OTW QP L and Sentus OTW QP S
• NCT02627196 - heart failure, sponsored by CVRx, Inc., study for Barostim Neo System
• NCT01742117 - coronary artery disease, acute coronary syndrome, stenosis; sponsored by Mayo Clinic, study for genotype testing and Clopidogrel or Ticagrelor

Learn more.

To learn more about clinical trials at Sharp, visit the Sharp Center for Research or send us an email.